Gladstone in the News
The Gladstone Institutes is gratified to receive media attention from around the globe. Check out the highlights of recent press coverage of Gladstone scientists and research. For other news, please be sure to follow us on Facebook and Twitter.
Using a method called optical pulse-labeling (OPL), researchers from the Gladstone Institutes discovered for the first time that neurons’ inability to clear toxic proteins associated with Huntington’s disease is responsible for protein buildup, which eventually causes the neurons to wither away.
Researchers are building upon Shinya Yamanaka's Nobel prize-winning discovery to improve methods of creating iPS cells.
People with epilepsy appear to show signs of mild memory problems or Alzheimer's disease earlier than those without epilepsy, according to a new Gladstone study.
Gladstone researcher Lennart Mucke shares his thoughts on when there might be a cure for Alzheimer's disease.
University of California's Larissa Branin sits down with Gladstone's Steve Finkbeiner to discuss his latest research into learning and memory.
EDGE presents a Q&A with Warner C. Greene, MD, PhD, director of virology and immunology research at the Gladstone Institutes in San Francisco.
A key protein that has been linked to the body’s natural circadian clock may provide insights into how the body regulates vital metabolic functions, according to new research.
ISSCR President and Nobel Laureate Shinya Yamanaka, MD, PhD, describes his research career in stem cell biology and regenerative medicine.
Scientists from the Gladstone Institute in San Francisco now believe they’ve mapped the process by which the human brain stores long-term memories in its cells.
According to a study reported in Nature Neuroscience, scientists from the Gladstone Institute have uncovered how a protein called Arc regulates the activity of neurons—providing much-needed clues into the brain’s ability to form long-lasting memories.